Prostate Cancer and Prostatic Diseases covers all aspects of prostatic diseases, in particular prostate cancer, the subject of intensive basic and clinical research world-wide. The journal also reports on exciting new developments being made in diagnosis, surgery, radiotherapy, drug discovery and medical management.
Prostate Cancer and Prostatic Diseases is of interest to surgeons, oncologists and clinicians treating patients and to those involved in research into diseases of the prostate. The journal covers the three main areas - prostate cancer, male LUTS and prostatitis.
Prostate Cancer and Prostatic Diseases publishes original research articles, reviews, topical comment and critical appraisals of scientific meetings and the latest books. The journal also contains a calendar of forthcoming scientific meetings. The Editors and a distinguished Editorial Board ensure that submitted articles receive fast and efficient attention and are refereed to the highest possible scientific standard. A fast track system is available for topical articles of particular significance.
The following is a non-exhaustive list of the general topics covered by Prostate Cancer and Prostatic Diseases:
Alternative therapies
Angiogenesis
Anti-sense oligonucleotides against growth factors
Brachytherapy
Conformal radiotherapy
Conformal radiotherapy
Cyclotron fast neutron treatment
Enhancing the results of radical prostatectomy
Epidemiology of prostate cancer and prostatic diseases
Familial prostate cancer
Free to total PSA
Gene therapy for prostate cancer
Genetic basis for prostate cancer Hormone-related disease
How significant is PSA-detected disease?
Intermittent antiandrogen therapy
Mechanisms of tumour invasion in prostate cancer
Medical and surgical therapies for male LUTS
Medical therapy for male LUTS: the road ahead
Natural history of prostate cancer and prostatic diseases
Nutrition in prostate cancer and prostatic diseases
Photodynamic therapy
Prognostic markers
Prostate cancer and potency and impotence
Prostatic intra-epithelial neoplasia - an important precursor of cancer
Prostatitis: quo vadis?
Quality of life issues
Racial issues in prostate cancer
Recurrence after radical prostatectomy
Reproducibility (test-retest reliability) of investigations for prostatic diseases
Reverse transcriptase polymerase chain reaction to detect circulating mRNA for PSA
Role of differentiation therapy
Screening for prostate cancer
Staging of prostate cancer: beyond conventional imaging
The magic bullet - use of PSA promotor gene to target gene therapy
Utility of ultrasensitive PSA assays

Original Articles
Systematic Reviews
Narrative Reviews
Letters to the Editor
Perspective
Brief Communication